PH94B in the Treatment of Adjustment Disorder With Anxiety

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 12, 2021

Primary Completion Date

December 14, 2022

Study Completion Date

December 14, 2022

Conditions

Adjustment Disorder With Anxious Mood

Interventions

DRUG

PH94B

Intranasal administration of 100 microliters to each nostril 4 times a day

DRUG

Placebo

Intranasal administration of 100 microliters to each nostril 4 times a day.

Trial Locations (2)

VistaGen Clinical Site, New York

VistaGen Clinical Site, Watertown

All Listed Sponsors

lead

VistaGen Therapeutics, Inc.

INDUSTRY

NCT04404192 - PH94B in the Treatment of Adjustment Disorder With Anxiety | Biotech Hunter | Biotech Hunter